ORIC Pharmaceuticals, Inc.
ORIC
$8.60
-$0.23-2.61%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -19.14% | 15.98% | 5.73% | -13.74% | -20.03% |
| Total Depreciation and Amortization | -10.60% | 5.26% | 6.67% | 13.97% | 15.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.47% | 69.18% | 62.19% | 121.59% | 107.69% |
| Change in Net Operating Assets | 52.85% | -62.01% | -10.30% | -123.17% | -3.91% |
| Cash from Operations | 0.29% | 19.86% | 12.80% | -20.36% | -7.78% |
| Capital Expenditure | 99.48% | -3.65% | 91.63% | 81.08% | -77.52% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -178.70% | -59.86% | -570.45% | -512.97% | 137.04% |
| Cash from Investing | -180.07% | -60.18% | -579.13% | -520.84% | 136.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 24,458.50% | 160.87% | 88,147.62% | 16,409.31% | -99.80% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -310.33% | -- | -- | -- | -44.05% |
| Cash from Financing | 555,718.18% | 160.87% | 86,765.87% | 16,358.58% | -99.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 206.50% | -126.35% | -367.70% | 506.34% | -130.54% |